EUVIMEDEUVIMED entdecken
Übersichtsarbeit

The Role of Botulinum Toxin A Neuromodulator in the Management of Synkinesis in Facial Palsy

Asalet Yener, Vikas Acharya, Peter Andrews, Catherine Meller, Eamon Shamil iD

Facial Plastic Surgery · 01.06.2025 · 41 (03) · 395-400

DOI: 10.1055/a-2370-2426 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Facial Plastic Surgery, erschienen am 01.06.2025. Verfasst von Asalet Yener und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division A, Department of Surgery, University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom. Hauptthemen laut MEDLINE: Synkinesis, Botulinum Toxins, Type A, Facial Paralysis, Neuromuscular Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 27 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Facial palsy describes the denervation of the facial nerve leading to difficulty in facial animation and expression. Facial synkinesis is the result of complex pathological nerve regeneration following damage to the facial nerve axons. Synkinesis in facial palsy can be managed using facial neuromuscular rehabilitation, botulinum toxin neuromodulators, and surgical treatment options. Botulinum toxin A can be used as an adjunct to other treatment options to manage synkinesis. This article will explore the role of botulinum toxin A in the management of synkinesis in facial palsy including the clinical assessment, injection location (muscles targeted), dosages, treatment interval, and long-term results. It will also include surgical management options.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SynkinesisBotulinum Toxins, Type AFacial ParalysisNeuromuscular AgentsHumansFacial MusclesFacial Nerve

Substanzen

Botulinum Toxins, Type ANeuromuscular Agents

Autor:innen und Institutionen

  • Division A, Department of Surgery, University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom.
  • Royal National ENT and EDH/UCLH and National Hospital of Neurology and Neurosurgery, University College London Hospitals NHS Foundation Trust, London, United Kingdom.
  • Post Graduate Clinical Training at Prince of Wales Hospital, Sydney, Australia.
  • Facial Reanimation and Facial Plastic and Reconstructive Surgery, Prince of Wales Hospital, Sydney, Australia.

ORCID-Profile: Eamon Shamil

Zitieren

APA

Yener, A., Acharya, V., Andrews, P., Meller, C., & Shamil, E. (2025). The Role of Botulinum Toxin A Neuromodulator in the Management of Synkinesis in Facial Palsy. Facial Plastic Surgery, 41(03), 395-400. https://doi.org/10.1055/a-2370-2426

Vancouver

Yener A, Acharya V, Andrews P, Meller C, Shamil E. The Role of Botulinum Toxin A Neuromodulator in the Management of Synkinesis in Facial Palsy. Facial Plastic Surgery. 2025;41(03):395-400. doi:10.1055/a-2370-2426

BibTeX
@article{Yener2025,
  author = {Yener, Asalet and Acharya, Vikas and Andrews, Peter and Meller, Catherine and Shamil, Eamon},
  title = {The Role of Botulinum Toxin A Neuromodulator in the Management of Synkinesis in Facial Palsy},
  journal = {Facial Plastic Surgery},
  year = {2025},
  volume = {41},
  number = {03},
  pages = {395--400},
  doi = {10.1055/a-2370-2426}
}
Kostenlos starten →